Quadracel 49281-0564-15
Generic: Diphtheria And Tetanus Toxoids And Acellular Pertussis Adsorbed And Inactivated Poliovirus Vaccine
- Manufacturer
- Sanofi Vaccines Us Inc.
- Dosage Form
- Injection, Suspension
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- March 24, 2015
- Listing Expires
- December 31, 2027
- Application
- BLA125525
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bordetella Pertussis Filamentous Hemagglutinin Antigen (formaldehyde Inactivated) | 20 ug/.5mL |
| Bordetella Pertussis Fimbriae 2/3 Antigen | 5 ug/.5mL |
| Bordetella Pertussis Pertactin Antigen | 3 ug/.5mL |
| Bordetella Pertussis Toxoid Antigen (glutaraldehyde Inactivated) | 20 ug/.5mL |
| Clostridium Tetani Toxoid Antigen (formaldehyde Inactivated) | 5 [Lf]/.5mL |
| Corynebacterium Diphtheriae Toxoid Antigen (formaldehyde Inactivated) | 15 [Lf]/.5mL |
| Poliovirus Type 1 Antigen (formaldehyde Inactivated) | 29 [D'ag'U]/.5mL |
| Poliovirus Type 2 Antigen (formaldehyde Inactivated) | 7 [D'ag'U]/.5mL |
| Poliovirus Type 3 Antigen (formaldehyde Inactivated) | 26 [D'ag'U]/.5mL |
Drug Class
Actively Acquired Immunity [PE]Actively Acquired Immunity [PE]Actively Acquired Immunity [PE]
Selected Package
49281-0564-15Selected10 SYRINGE in 1 PACKAGE (49281-564-15) / .5 mL in 1 SYRINGE (49281-564-88)
Other packages for this product(1)
10 VIAL, SINGLE-USE in 1 PACKAGE (49281-564-10) / .5 mL in 1 VIAL, SINGLE-USE (49281-564-58)